Old Web
English
Sign In
Acemap
>
authorDetail
>
Kaweczyńska-Lasoń A
Kaweczyńska-Lasoń A
Hoffmann-La Roche
Medicine
Kidney transplantation
Cytomegalovirus disease
Valganciclovir
Clinical trial
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
[The evaluation of cost-effectiveness and cost-utility of valganciclovir for the prophylaxis of cytomegalovirus disease to 200 days after kidney transplantation].
2013
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
Paweł Kawalec
Przemysław Holko
Monika Szkultecka-Dębek
Anna Paszulewicz
M. Boratyńska
M. Glyda
Ignacak E
Maks J
M Russel-Szymczyk
Kaweczyńska-Lasoń A
Show All
Source
Cite
Save
Citations (0)
Clinical efficacy and safety of prolonged use of the valganciclovir for the treatment of cytomegalovirus disease in patients after kidney transplantation
2013
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
Paweł Kawalec
Monika Szkultecka-Dębek
Maks J
Anna Paszulewicz
Kaweczyńska-Lasoń A
Andrzej Pilc
Show All
Source
Cite
Save
Citations (0)
1